PARTERS VII L P DOMAIN
CIK 1374150 · last filed 2014-03-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$11.45M
Companies
7
Total Filings
20
Lifetime Open-Market Net
$48.85M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Achaogen, Inc. (AKAO) Delisted | 10%+ Owner | 1,987,049 | — | — | $0 | 1 | 2014-03-17 |
| TNDM | 10%+ Owner | 318,906 | $18.10 | $5.77M | $0 | 1 | 2013-11-19 |
| Evoke Pharma Inc (OMED) Delisted | 10%+ Owner | 1,114,327 | — | — | $0 | 1 | 2013-09-30 |
| ESPR | 10%+ Owner | 1,786,012 | $3.18 | $5.68M | $3.93M | 1 | 2013-07-02 |
| Orexigen Therapeutics, Inc. (OREX) Delisted | 10%+ Owner | 296,742 | — | — | $16.89M | 12 | 2011-12-22 |
| Clovis Oncology, Inc. (CLVS) Delisted | 10%+ Owner | 1,704,080 | $0.08 | $138.4K | $11.91M | 1 | 2011-11-21 |
| ZOGENIX, INC. (ZGNX) Delisted | 10%+ Owner | 1,240,417 | $26.68 | $33.09M | $16.12M | 2 | 2011-09-20 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2009-11-25 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +49,161 | $331.8K | EDGAR |
| 2009-11-24 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +393,292 | $2.73M | EDGAR |
| 2009-11-16 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +60,960 | $420.6K | EDGAR |
| 2009-11-12 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +135,686 | $940.3K | EDGAR |
| 2009-08-19 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +13,553 | $104.8K | EDGAR |
| 2009-08-18 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +87,926 | $681.0K | EDGAR |
| 2009-08-14 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +406,074 | $3.25M | EDGAR |
| 2009-08-13 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +102,551 | $779.4K | EDGAR |
| 2009-07-24 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +639,099 | $4.79M | EDGAR |
| 2008-12-11 | Orexigen Therapeutics, Inc. (OREX) Delisted | Buy (P) | +237,826 | $1.17M | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.